國立虎尾科技大學 |

Antidepressants = From Biogenic Amines to New Mechanisms of Action /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Antidepressants/ edited by Matthew Macaluso, Sheldon H. Preskorn.
其他題名:	From Biogenic Amines to New Mechanisms of Action /
其他作者:	Macaluso, Matthew.
面頁冊數:	XII, 442 p. 17 illus., 8 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmacology. -
電子資源:	https://doi.org/10.1007/978-3-030-10949-3
ISBN:	9783030109493

Antidepressants = From Biogenic Amines to New Mechanisms of Action /
AntidepressantsFrom Biogenic Amines to New Mechanisms of Action /[electronic resource] :edited by Matthew Macaluso, Sheldon H. Preskorn. - 1st ed. 2019. - XII, 442 p. 17 illus., 8 illus. in color.online resource. - Handbook of Experimental Pharmacology,2500171-2004 ;. - Handbook of Experimental Pharmacology,224.

Part 1: Overview and General Principles -- 1. Impact, Diagnosis, Phenomenology, and Biology -- Part 2: The Past – from antiquity to 1970 including TCAs and MAOIs -- 2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? -- Part 3: The Present- 1970 to 2016 -- 3. Clinical Implications of the STAR*D Trial -- 4. Pharmacogenomics and Biomarkers of Depression -- 5. Therapeutic Drug Monitoring of Antidepressants -- 6. Selective Serotonin Reuptake Inhibitors -- 7. Serotonin and Norepinephrine Reuptake Inhibitors -- 8. Neurostimulation Therapies -- 9. Current Role of Herbal and Natural Preparations -- Part 4: The future -- 10. Role of Inflammation in Depression and Treatment Implications -- 11. NMDA Antagonists for Treatment-Resistant Depression -- 12. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- 13. Other Antidepressants -- Part 5: Use of Antidepressants in Special Populations -- 14. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders -- 15. Treatment of Depression in Women -- 16. Management of Late-Life Depression -- 17. The Use of Antidepressants in Bipolar Depression.

This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.

ISBN: 9783030109493

Standard No.: 10.1007/978-3-030-10949-3doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: RM1-950

Dewey Class. No.: 615

Antidepressants = From Biogenic Amines to New Mechanisms of Action /
LDR:02867nam a22003975i 4500 001 1011638
003 DE-He213
005 20200705105142.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030109493 $9 978-3-030-10949-3
024 7 $a 10.1007/978-3-030-10949-3 $2 doi
035 $a 978-3-030-10949-3
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
245 1 0 $a Antidepressants $h [electronic resource] : $b From Biogenic Amines to New Mechanisms of Action / $c edited by Matthew Macaluso, Sheldon H. Preskorn.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XII, 442 p. 17 illus., 8 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 250
505 0 $a Part 1: Overview and General Principles -- 1. Impact, Diagnosis, Phenomenology, and Biology -- Part 2: The Past – from antiquity to 1970 including TCAs and MAOIs -- 2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? -- Part 3: The Present- 1970 to 2016 -- 3. Clinical Implications of the STAR*D Trial -- 4. Pharmacogenomics and Biomarkers of Depression -- 5. Therapeutic Drug Monitoring of Antidepressants -- 6. Selective Serotonin Reuptake Inhibitors -- 7. Serotonin and Norepinephrine Reuptake Inhibitors -- 8. Neurostimulation Therapies -- 9. Current Role of Herbal and Natural Preparations -- Part 4: The future -- 10. Role of Inflammation in Depression and Treatment Implications -- 11. NMDA Antagonists for Treatment-Resistant Depression -- 12. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- 13. Other Antidepressants -- Part 5: Use of Antidepressants in Special Populations -- 14. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders -- 15. Treatment of Depression in Women -- 16. Management of Late-Life Depression -- 17. The Use of Antidepressants in Bipolar Depression.
520 $a This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.
650 0 $a Pharmacology. $3 583819
650 0 $a Psychopharmacology. $3 644799
650 0 $a Neurosciences. $3 593561
650 1 4 $a Pharmacology/Toxicology. $3 593882
700 1 $a Macaluso, Matthew. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1226711
700 1 $a Preskorn, Sheldon H. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1226712
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030109486
776 0 8 $i Printed edition: $z 9783030109509
830 0 $a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 224 $3 1254015
856 4 0 $u https://doi.org/10.1007/978-3-030-10949-3
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)